Osteopathic Medicine in Fibromyalgia Syndrome (FIBROPATHIC)
Primary Purpose
Fibromyalgia Syndrome
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Osteopathic treatment
Factitious osteopathic treatment
Sponsored by
About this trial
This is an interventional treatment trial for Fibromyalgia Syndrome focused on measuring Fibromyalgia syndrome, pain, quality of life, osteopathic treatment
Eligibility Criteria
Inclusion Criteria:
- Patient Male or female aged at least of 18
- Patient with fibromyalgia, according to the American College of Rheumatology (ACR) 1990 criteria, with a global level of pain of 50 over a 100 mm EVA scale
- Patient suffering from fibromyalgia for over a year
- Patient with stable medical/non medical treatment for at least 1 month before the recruitment
- Patient referred to a medical center for a multidisciplinary approach
- Patient who can be followed for at least 12 months after the end of the osteopathic sessions
- Patient giving his informed consent to participate in the study
- Patient affiliated to or beneficiary of social insurance
Exclusion Criteria:
- Treatment by physical approach in progress or not older than 3 months : physiotherapy, kinesitherapy, rehabilitation or manual treatment (osteopathic or chiropractic care, manual medicine)
- Unability to attend 6 sessions, meaning one weekly session, of osteopathy, at Hôtel Dieu
- Severe psychiatric pathology : major depression, psychosis
- Pregnancy or breast feeding
- The patient is already included in another clinical study
- Patient under judicial protection
Sites / Locations
- Hotel-Dieu Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Osteopathy +
Osteopathy -
Arm Description
75 patients will make 6 osteopathic sessions
75 patients will make 6 factitious osteopathic sessions
Outcomes
Primary Outcome Measures
Evaluation of pain during the 6 weeks of osteopathic treatment
The assessment will be on the declarative of the patient. He will report every week the intensity of pain measured by a numeric scale (0 to 100).
Secondary Outcome Measures
Quality of life
Questionnaires: Fibromyalgia Impact Questionnaire (FIQ) and SF-36 (Short Form health survey)
Quality of life
Questionnaires: FIQ and SF-36
Quality of life
Questionnaires: FIQ and SF-36
Quality of life
Questionnaires: FIQ and SF-36
Fatigue
Questionnaires: multidimensional fatigue inventory (MFI) scale
Fatigue
Questionnaires: MFI scale
Fatigue
Questionnaires: MFI scale
Fatigue
Questionnaires: MFI scale
Pain
Questionnaires: Brief Pain Inventory (BPI)
Pain
Questionnaires: BPI
Pain
Questionnaires: BPI
Pain
Questionnaires: BPI
Full Information
NCT ID
NCT02343237
First Posted
January 15, 2015
Last Updated
April 15, 2019
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT02343237
Brief Title
Osteopathic Medicine in Fibromyalgia Syndrome
Acronym
FIBROPATHIC
Official Title
A Multicenter, Randomized Study, Against Credible Factitious Intervention That Evaluates the Interest of Osteopathic Medicine in the Management of Fibromyalgia Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
December 2, 2015 (Actual)
Primary Completion Date
July 20, 2017 (Actual)
Study Completion Date
July 27, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.
Detailed Description
An osteopathic treatment could have a positive and durable effect on pain and quality of life on patients with fibromyalgia.
This technique, in addition to the standard treatment in a multidisciplinary care center, could be efficient by releasing muscle tension.
This is a 24 months multicenter (2 recruiting centers, 1 care center), randomized, and placebo-controlled study. The purpose is to evaluate the analgesic efficacy of a 6 weeks osteopathic treatment compared to a 6 week standard treatment on patients with fibromyalgia. It includes 6 osteopathic/standard sessions of 20 minutes (of one week apart), a follow-up at 3 months, 6 months and 12 months.
The primary aim of this study is to evaluate the pain after each osteopathic session, at the end of the 6 weeks treatment, and after each visit, judging by the patient's pain measured by a numeric scale (EVA).
The secondary aims of this study, based on clinical exams and questionnaires are to evaluate the quality of life, the patient activity and the sleep improvement after osteopathic treatment, and to investigate if osteopathic medicine improves fatigue, comorbidities, and decrease additional visits and medical investigations.
This study will also allow to identify the profile of the osteopathic treatment responders patients
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia Syndrome
Keywords
Fibromyalgia syndrome, pain, quality of life, osteopathic treatment
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
101 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Osteopathy +
Arm Type
Experimental
Arm Description
75 patients will make 6 osteopathic sessions
Arm Title
Osteopathy -
Arm Type
Active Comparator
Arm Description
75 patients will make 6 factitious osteopathic sessions
Intervention Type
Procedure
Intervention Name(s)
Osteopathic treatment
Intervention Description
osteopathic sessions of 20 minutes
Intervention Type
Procedure
Intervention Name(s)
Factitious osteopathic treatment
Intervention Description
6 factitious osteopathic sessions of 20 minutes
Primary Outcome Measure Information:
Title
Evaluation of pain during the 6 weeks of osteopathic treatment
Description
The assessment will be on the declarative of the patient. He will report every week the intensity of pain measured by a numeric scale (0 to 100).
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Quality of life
Description
Questionnaires: Fibromyalgia Impact Questionnaire (FIQ) and SF-36 (Short Form health survey)
Time Frame
6 weeks after osteopathic treatment
Title
Quality of life
Description
Questionnaires: FIQ and SF-36
Time Frame
3 months after osteopathic treatment
Title
Quality of life
Description
Questionnaires: FIQ and SF-36
Time Frame
6 months after osteopathic treatment
Title
Quality of life
Description
Questionnaires: FIQ and SF-36
Time Frame
1 year after osteopathic treatment
Title
Fatigue
Description
Questionnaires: multidimensional fatigue inventory (MFI) scale
Time Frame
6 weeks after osteopathic treatment
Title
Fatigue
Description
Questionnaires: MFI scale
Time Frame
3 months after osteopathic treatment
Title
Fatigue
Description
Questionnaires: MFI scale
Time Frame
6 months after osteopathic treatment
Title
Fatigue
Description
Questionnaires: MFI scale
Time Frame
1 year after osteopathic treatment
Title
Pain
Description
Questionnaires: Brief Pain Inventory (BPI)
Time Frame
6 weeks after osteopathic treatment
Title
Pain
Description
Questionnaires: BPI
Time Frame
3 months after osteopathic treatment
Title
Pain
Description
Questionnaires: BPI
Time Frame
6 months after osteopathic treatment
Title
Pain
Description
Questionnaires: BPI
Time Frame
1 year after osteopathic treatment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient Male or female aged at least of 18
Patient with fibromyalgia, according to the American College of Rheumatology (ACR) 1990 criteria, with a global level of pain of 50 over a 100 mm EVA scale
Patient suffering from fibromyalgia for over a year
Patient with stable medical/non medical treatment for at least 1 month before the recruitment
Patient referred to a medical center for a multidisciplinary approach
Patient who can be followed for at least 12 months after the end of the osteopathic sessions
Patient giving his informed consent to participate in the study
Patient affiliated to or beneficiary of social insurance
Exclusion Criteria:
Treatment by physical approach in progress or not older than 3 months : physiotherapy, kinesitherapy, rehabilitation or manual treatment (osteopathic or chiropractic care, manual medicine)
Unability to attend 6 sessions, meaning one weekly session, of osteopathy, at Hôtel Dieu
Severe psychiatric pathology : major depression, psychosis
Pregnancy or breast feeding
The patient is already included in another clinical study
Patient under judicial protection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Serge PERROT, PU-PH
Organizational Affiliation
+ 33 1.42.34.84.49
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hotel-Dieu Hospital
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75004
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Osteopathic Medicine in Fibromyalgia Syndrome
We'll reach out to this number within 24 hrs